| 000 | 01489 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516213138.0 | ||
| 264 | 0 | _c20150720 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1520-5711 | ||
| 024 | 7 |
_a10.1080/10543406.2014.919933 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarry, William T | |
| 245 | 0 | 0 |
_aThe use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies. _h[electronic resource] |
| 260 |
_bJournal of biopharmaceutical statistics _c2015 |
||
| 300 |
_a66-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aClinical Trials, Phase II as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aSample Size |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPerou, Charles M | |
| 700 | 1 | _aMarcom, P Kelly | |
| 700 | 1 | _aCarey, Lisa A | |
| 700 | 1 | _aIbrahim, Joseph G | |
| 773 | 0 |
_tJournal of biopharmaceutical statistics _gvol. 25 _gno. 1 _gp. 66-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10543406.2014.919933 _zAvailable from publisher's website |
| 999 |
_c23833383 _d23833383 |
||